In silico modeling of Plasmodium falciparum chloroquine resistance transporter protein and biochemical studies suggest its key contribution to chloroquine resistance
- PMID: 30308208
- DOI: 10.1016/j.actatropica.2018.10.001
In silico modeling of Plasmodium falciparum chloroquine resistance transporter protein and biochemical studies suggest its key contribution to chloroquine resistance
Abstract
Chloroquine (CQ) has been used for decades as the primary chemotherapeutic drug for the treatment of malaria. The emergence of drug resistance in Plasmodium falciparum has been considered to be because of the excessive use of antimalarial drugs worldwide. Moreover, the intense distribution and prevalence of chloroquine-resistant strains in endemic regions has aided the incidence of more complications to malaria treatment and control. Due to the lack of literature that portrays evident molecular mechanisms of drug resistance, it has been difficult to understand the drug resistance conferred by Plasmodium species. Intensive research on CQ drug resistance has identified the association of P. falciparum chloroquine resistance transporter protein (PfCRT), which belongs to the drug/metabolite transporter and EamA-like superfamily. Additionally, it has shown that K76 T mutation in PfCRT protein has mainly attributed to CQ resistance than other mutations. This study deals with the development of an in silico model of the PfCRT protein and its interaction with the CQ ligand molecule as well as the biochemical and biophysical characterization of the transmembrane domain 1 (TMD 1) peptide of the PfCRT protein. The physiochemical analysis of the PfCRT protein identified basic differences between the wild and mutant forms of the protein, as well as identifying the high hydrophobic nature of the mutant-type protein. The tertiary structure of the PfCRT protein was predicted and interaction with CQ revealed different active pocket binding regions in both the wild and mutant form of PfCRT proteins. The CQ2+ molecule interacts with TMD 10 of the wild-type PfCRT protein, whereas it interacts with TMD 1 of the mutant-type protein. Studies on the TMD 1 peptide revealed the insertion of the peptide in the micelles adopting stable alpha-helical structure. Binding studies with the CQ molecule detected high binding affinity toward the mutant-type TMD 1 peptide rather than the wild-type, thus confirming that the TMD 1 peptide is involved in substrate selectivity. Our findings help to characterize the structure of the PfCRT protein and the role played by the TMD 1 region in CQ resistance using in silico and biochemical approaches. Molecular docking and ligand binding studies confirm that TMD 1 is involved in substrate selectivity and aids in CQ efflux, thereby contributing to the parasite's CQ drug resistance mechanism.
Keywords: Chloroquine; Molecular docking; P. falciparum chloroquine resistance transporter protein (PfCRT); Tertiary structure prediction; Transmembrane domain (TMD).
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.ACS Infect Dis. 2017 Feb 10;3(2):119-131. doi: 10.1021/acsinfecdis.5b00141. Epub 2016 Dec 7. ACS Infect Dis. 2017. PMID: 28183182
-
Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.Virulence. 2010 Jul-Aug;1(4):304-8. doi: 10.4161/viru.1.4.12012. Virulence. 2010. PMID: 21178460
-
Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.Trends Parasitol. 2007 Jul;23(7):332-9. doi: 10.1016/j.pt.2007.04.013. Epub 2007 May 10. Trends Parasitol. 2007. PMID: 17493873 Review.
-
Chloroquine transport via the malaria parasite's chloroquine resistance transporter.Science. 2009 Sep 25;325(5948):1680-2. doi: 10.1126/science.1175667. Science. 2009. PMID: 19779197
-
pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective.Acta Trop. 2005 Jun;94(3):170-80. doi: 10.1016/j.actatropica.2005.04.004. Acta Trop. 2005. PMID: 15866507 Review.
Cited by
-
Alkaloidal Extracts from Avicennia africana P. Beauv. (Avicenniaceae) Leaf: An Antiplasmodial, Antioxidant, and Erythrocyte Viable.Adv Pharmacol Pharm Sci. 2024 Jan 9;2024:4541581. doi: 10.1155/2024/4541581. eCollection 2024. Adv Pharmacol Pharm Sci. 2024. PMID: 38235482 Free PMC article.
-
An Overview of Drug Resistance in Protozoal Diseases.Int J Mol Sci. 2019 Nov 15;20(22):5748. doi: 10.3390/ijms20225748. Int J Mol Sci. 2019. PMID: 31731801 Free PMC article. Review.
-
Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in Plasmodium falciparum.J Biol Chem. 2019 Aug 23;294(34):12766-12778. doi: 10.1074/jbc.RA119.009464. Epub 2019 Jul 8. J Biol Chem. 2019. PMID: 31285265 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources